U.S. Communications Stock News

Recent insider activity at Q2 Holdings (QTWO) has attracted attention, with nearly US$23 million of shares sold over the past three months and no insider buying. This has prompted questions about alignment between management and shareholders. See our latest analysis for Q2 Holdings. At a share price of US$47.98, Q2 Holdings has seen a 4.60% 1 day share price gain but a 90 day share price return decline of 30.27%, alongside a 36.40% 1 year total shareholder return decline and a very large 3...

Recently, SLB announced that its OneSubsea joint venture won a high-pressure, high-temperature multiphase boosting contract for Beacon Offshore’s Shenandoah deepwater field in the Gulf of America, alongside a long-term collaboration framework with PETRONAS Suriname and Subsea7 for integrated subsea developments in Suriname. These agreements underline how SLB’s advanced subsea and digital capabilities are being written into multi-year offshore development plans, potentially reinforcing the...

FDA grants Priority Review to ifinatamab deruxtecan, a B7-H3 antibody drug conjugate co-developed by Merck (NYSE:MRK) and Daiichi Sankyo. The filing covers adults with extensive-stage small cell lung cancer whose disease has relapsed after chemotherapy. If approved, this would be the first B7-H3 targeted medicine available for any cancer. For investors watching NYSE:MRK, this Priority Review highlights fresh momentum in Merck’s oncology pipeline alongside its existing cancer portfolio. The...

Rumors emerged that Nvidia is exploring an acquisition of a major PC manufacturer, with speculation centering on Dell Technologies (NYSE:DELL). The report suggested a potential deal that could link Nvidia's chips with a large PC and server footprint. Nvidia later denied pursuing any such acquisition, but the initial headlines coincided with a sharp move higher in Dell's share price. Dell Technologies sits at the intersection of PCs, servers, storage and enterprise solutions, which places it...

Wondering whether Gilead Sciences at around US$139 a share still offers value or if most of the opportunity is already reflected in the price, this article breaks that question down in plain terms. The stock shows a mixed recent picture, with a 0.2% return over the last 7 days, a 4.1% decline over 30 days, a 14.3% return year to date and a 35.1% return over 1 year that some investors may read as a strong payoff for sticking with the name. Recent coverage has focused on how Gilead Sciences...

In March 2026, West Pharmaceutical Services opened a new 165,000 square foot building at its Damastown, Dublin site, expanding contract services to include advanced automation and commercial-scale drug-handling capabilities for high-volume treatments such as diabetes and obesity therapies. This expansion deepens the West Vantage single-source offering across development, manufacturing, packaging, and regulatory support, aiming to streamline customers' paths from concept to commercial supply...

If you have been wondering whether Revvity is starting to look interesting on price, this breakdown will help you make sense of where the value case currently stands. Revvity shares last closed at US$92.64, after returns of 4.9% over the past week and 8.3% over the past month, while the year to date return is a 5.6% decline and the 1 year return is a 4.8% decline. These recent moves sit against a longer record that includes a 31.3% decline over 3 years and a 30.4% decline over 5 years, which...

Oklo (NYSE:OKLO) expects its first reactor to reach operational criticality by July 4. Criticality would mean achieving a self-sustaining nuclear reaction in the company’s initial microreactor. This milestone is important for moving Oklo’s advanced microreactor technology toward commercial use. Oklo focuses on advanced microreactors designed to provide compact nuclear power solutions. For investors watching the nuclear and clean energy space, this expected criticality event marks a shift in...

MediWound Ltd. recently announced that Vericel, its exclusive North American distributor for NexoBrid, secured a ten-year BARDA contract worth up to US$197 million to fund NexoBrid procurement, vendor-managed inventory, potential U.S. manufacturing, and development of new indications and formulations. The contract’s mix of immediate stockpile purchases, inventory services, and longer-term development funding highlights how government preparedness priorities can underpin Vericel’s burn-care...

If you are wondering whether Dollar Tree is attractively priced after a volatile few years, this article walks through how its current share price stacks up against several valuation checks. The stock closed at US$102.13, with returns of an 8.1% decline over 7 days, a 5.0% decline over 30 days, a 20.0% decline year to date, but 38.6% over 1 year, highlighting how quickly sentiment around value and risk can shift. Recent coverage has focused on Dollar Tree's repositioning within value retail...

Why Autohome is on investors’ radar today Autohome (NYSE:ATHM) is drawing attention after a period of mixed share performance, with the stock showing a small move over the past week but weaker returns over the past month and past 3 months. See our latest analysis for Autohome. At a share price of $17.85, Autohome’s 7 day share price return of 2.12% sits against a weaker backdrop, with a 30 day share price return of 5.36% and a 1 year total shareholder return decline of 26.91%, suggesting...

Wondering if Brink's at around US$106.84 is still offering value or if the easy money has already been made? This article walks through what the current price might imply about expectations baked into the stock. Over the past year the share price has returned 23.0%, with a 3.1% gain over the last 7 days, a roughly flat 30 day move at 0.2% decline, and a 8.3% decline year to date, which may catch the eye of investors thinking about risk and entry points. Recent headlines around Brink's have...

If you are wondering whether Micron Technology's current share price still offers value after a big run, this breakdown will help you frame what you are really paying for. The stock last closed at US$426.56, with returns of 13.0% over 7 days, 0.1% over 30 days, 35.2% year to date, and a very large return over 1 year and 3 years. This naturally raises questions about what is already priced in and how risk has shifted. Recent coverage has focused on Micron as a key beneficiary of interest in...

Wondering if American Superconductor at around US$37.81 is still offering value or if you are arriving late to the story? This article walks through what the current price might imply for you as a shareholder or potential buyer. The stock has posted returns of 15.9% over 7 days, 21.9% over 30 days and 19.7% year to date, with 108.0% over 1 year and a very large gain over 3 years that is around 7x. Those moves can quickly change how comfortable you feel about the current valuation and future...

Visa (NYSE:V) has partnered with Neat to roll out AI-powered embedded insurance and medical assistance to over 25 million Visa cardholders in France, with a wider European rollout planned. The company has also launched an Exchange Offer allowing holders of its Class B shares to convert them into freely tradable Class C shares, with cash paid for fractional shares. Both moves are aimed at integrating higher value services into Visa's payment network and simplifying its share structure for...

On 9 April 2026, Norton, part of Gen Digital, launched the beta of Norton AI Agent Protection in Norton 360 for Windows, adding real-time oversight of AI agents’ actions to help users stay in control of tools like Claude Code, Cursor, and OpenClaw. This move highlights how Gen Digital is extending cyber safety beyond devices to the emerging layer of autonomous AI agents that can access sensitive personal data. We’ll now explore how this new AI agent oversight capability could influence Gen...

Stanley Black & Decker (NYSE:SWK) has completed the sale of its Consolidated Aerospace Manufacturing business for approximately $1.8b in cash. The company plans to use the proceeds to pay down debt and sharpen its focus on core tools and industrial operations. Separately, Stanley Black & Decker has closed its last manufacturing plant in New Britain, ending more than 180 years of production in the city. For investors following Stanley Black & Decker at a share price of $72.35, these moves...

Nelnet (NNI) is back on investors’ radar after recent trading pushed the share price to a last close of $133.21. This has prompted fresh attention on its mix of loan servicing, education technology, and banking activities. See our latest analysis for Nelnet. The recent move to $133.21 caps a mixed few months for Nelnet’s share price, with a modest 30 day share price return of 2.60% contrasting with a 90 day share price return of a 1.40% decline, while the 1 year total shareholder return of...

Sunbelt Rentals Holdings (SUNB) recently reported rental revenue growth and robust adjusted EBITDA, along with higher full-year capital expenditure plans for fleet expansion and acquisitions, plus a new multi billion dollar share repurchase program. See our latest analysis for Sunbelt Rentals Holdings. The recent capital spending update and new buyback come against a mixed backdrop for the shares, with a 9.45% 7 day share price return, a 4.84% 1 month decline, and a 32.33% 1 year total...

Blackstone (NYSE:BX) is working with I Squared Capital on a potential bid for Stroer’s core European advertising business. The firm has launched a planned US$2b Digital Infrastructure Trust IPO as part of its build out in digital assets. Blackstone and TPG have completed an US$18.3b acquisition of Hologic, expanding further into healthcare. Oppenheimer has raised its rating on Blackstone to Outperform, citing renewed confidence in the firm. For investors watching NYSE:BX, these moves...

Coca-Cola Consolidated, Inc. announced on April 10, 2026 that its Board of Directors declared a second quarter 2026 dividend of US$0.25 per share on its Common Stock and Class B Common Stock, payable on May 8, 2026 to shareholders of record as of April 24, 2026. This latest declaration extends the company’s decades-long pattern of uninterrupted dividends, underscoring the importance of consistent cash returns for income-focused investors. We’ll now examine how this reaffirmed quarterly...

In recent days, Affirm Holdings has stayed in focus as analysts largely maintained positive ratings and highlighted strong investor demand for its loans, even as a director transferred a substantial block of shares to a former spouse as part of a divorce settlement. The combination of bullish analyst commentary and an upsized asset-backed securities issuance suggests that capital markets remain receptive to Affirm’s funding needs despite macroeconomic uncertainty. Next, we’ll examine how...

If you are wondering whether Federated Hermes at around US$56.30 is still reasonably priced after a strong run, a clear look at value can help you decide how it might fit into your portfolio. The stock recently closed at US$56.30, with a 7.5% return year to date and a 51.7% return over the past year, alongside shorter term moves of a 2.2% decline over 7 days and a 1.2% decline over 30 days. Recent news has focused on Federated Hermes as a diversified financials player in the capital markets...

Illumina recently announced that three long-serving directors, Drs. Frances Arnold, Robert S. Epstein and Gary S. Guthart, will retire from its board at the 2026 annual meeting, while the company prepares to report first-quarter 2026 results on April 30. At the same time, Illumina’s expanded collaboration with Labcorp in precision oncology highlights how its sequencing platforms are being tied more closely to real-world clinical testing and patient selection for targeted therapies. Against...